Yasin Keshvargar
Lawyers
Filters
Tempus AI $410 million IPO
The stock is listed on the Nasdaq Global Select Market
Perspective Therapeutics $80 million offering
The stock is listed on the NYSE American
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
GXO Logistics $1.1 billion notes offering
The investment-grade notes are due 2029 and 2034
Korro Bio $70 million private placement
The PIPE consists of common stock
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Borse Dubai $1.8 billion secondary offering of Nasdaq shares
We advised Borse Dubai on the offering
Beazer Homes USA $250 million notes offering
The high-yield notes are due 2031
Exchange transaction for Sabre exchangeable notes
We advised Sabre on its exchange of exchangeable senior notes
Sabre private exchange
We advised Sabre on its exchange of senior secured notes